- Monographs -

PCA Drug Libraries: Designing, Implementing, and Analyzing CQI Reports to Optimize Patient Safety

Program Description This monograph addresses recommendations from ISMP for safe use of PCA and is designed to assist readers in organizing and implementing a CQI process to optimize PCA use and minimize medication errors.

Learning Objectives

Upon completion of this activity, pharmacists and nurses will be able to:

• Describe the recommendations of the Institute of Medicine (IOM) report Preventing Medication

• Errors on infusion therapy and the current state of "smart" pump use in U.S. hospitals.

• Understand the causes of serious adverse drug events associated with PCA infusion.

• Organize a multidisciplinary team to build a drug library for safe PCA administration.

• Describe how to utilize data from PCA smart pumps for continuous quality improvement.

Program Faculty

Allen J. Vaida, PharmD, FASHP
Executive Vice President
Institute for Safe Medication Practices
Huntingdon Valley, PA

Matthew Grissinger, RPh, FASCP
Medication Safety Analyst
Institute for Safe Medication Practices
Huntingdon Valley, PA

Barbara Urbanski, MS, RN
Clinical Nurse Specialist
University of Michigan Hospitals
Ann Arbor, MI

John F. Mitchell, PharmD, FASHP
Medication Safety Coordinator
University of Michigan Health Service
Ann Arbor, MI

CE Accreditation:

Pharmacists:
Continuing education (CE) credit will be provided by the Pediatric Pharmacy Advocacy Group (PPAG). PPAG is an approved provider of continuing pharmacy education by the Accreditation Council for Pharmacy Education. This program (180-999-07-504-H04) is approved for 1.5 contact hours (.15 CEUs) of CE credit, and is provided free of charge. Pharmacists who complete the program may take the test and print their CE statements from the Institute of Safe Medication Practices (ISMP) website at www.ismp.org/druglibraryce.

The release date of this program is May 1, 2007 and the expiration date is May 1, 2010.

Nurses:
Debora Simmons Bennett is approved by the California Board of Nurse Examiners as a provider of continuing nursing education. This program (CEP 13677) is approved for 1.0 contact hours (0.1 CEUs) of continuing nursing education. Nurses who complete the program may take the test and print their CE statements from the ISMP website at www.ismp.org/druglibraryce/.

The release date of this program is May 1, 2007 and the expiration date is May 1, 2010.

Disclosure Statements

It is the policy of PPAG to ensure independence, balance, objectivity, and scientific rigor in all its individually or jointly presented education programs. All faculty participating in PPAG programs are expected to disclose any real or apparent conflict(s) of interest that may have a direct or indirect bearing on the subject matter of the continuing education program. Disclosure pertains to relationships with any pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related or unrelated to the subject matter of the presentation topic.